Dear Department of Health and Social Care,
For the period 1 April 2022 to 6 September 2022
All direct communications between Professor James Palmer with the Antivirals and Therapeutics Taskforce (should this have its own email address or electronic identity) in which Evusheld (i.e. the combination of Tixagevimab and cilgavimab, AZD7742 or any other name that is used by the DHSC for this) is mentioned, whether by email or other electronic means.
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1428148).
Freedom of Information Team
Department of Health and Social Care
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.Donate Now